Log In
Print
BCIQ
Print
Print this Print this
 

Anti-CD38

  Manage Alerts
Collapse Summary General Information
Company Amorfix Life Sciences Ltd.
DescriptionMAb against CD38 disease specific epitopes (DSEs)
Molecular Target CD38
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner

Apexigen Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today